ポスト

<進行再発乳がん関連/MBC> Abstract #1003 First-line inavolisib/placebo + palbociclib + fulvestrant (Inavo/Pbo+Palbo+Fulv) in patients (pts) with PIK3CA-mutated, hormone receptor-positive, HER2‑negative locally advanced/metastatic breast cancer who relapsed during/within 12 months…

メニューを開く

Mitsuo Terada, MD, PhD@乳腺科医@MamMa_mimumemo

みんなのコメント

メニューを開く

<早期乳がん関連/EBC> Abstract #503 ECOG-ACRIN EAZ171: Prospective validation trial of germline variants and taxane type in association with taxane-induced peripheral neuropathy (TIPN) in Black women with early-stage breast cancer. meetings.asco.org/abstracts-pres… Abstract #504 Impact of…

Mitsuo Terada, MD, PhD@乳腺科医@MamMa_mimumemo

人気ポスト

もっと見る
Yahoo!リアルタイム検索アプリ